Microsoft teams up with Paige on AI-powered cancer detection

Microsoft Corp (NASDAQ: MSFT) has partnered with Paige on the world’s largest AI model for detecting cancer.

Paige has a history of winning FDA approval

The image-based model can help identify not just common cancers but the rare ones as well that are broadly known as hard to diagnose. According to Andy Moye – the Chief Executive of Paige:

Paige has already secured FDA approval for its AI solution that helps identify prostate cancer. The digital pathology company now plans on working with Microsoft on a new AI tool that spots more cancer types.

Earlier this week, Microsoft was reported to have invested in d-Matrix – a Silicon Valley-based AI chip startup. Its shares are up close to 40% versus start of the year at writing.

Paige has a wealth of data to train the AI model

An AI-backed solution that pathologists can use as a secondary tool to ascertain cancers with increased accuracy and efficiency will like help with staff shortages and increasing caseloads.

Note that Paige has a wealth of data to train the said AI model that far exceeds the amount of data on the world’s largest streaming platform – Netflix. Desney Tan – the Vice President of Microsoft Health Futures said today in a press release:

Paige has been employing supercomputing infrastructure as well as cloud storage of Microsoft to develop an advanced AI model since early last year.